Encision Inc. Announces Fiscal 2026 Fourth Quarter and Full Year Results 
Court Rules Against Jason Shurka in EESystem Case; $54,034 in Federal Sanctions Ordered
Clark County judge finds defendant's public statements were not made in good faith. The ruling caps months of legal proceedings...
Seniors Being Used As CBD Guinea Pigs In CMS Program?
MMJ International Holdings Moves to Join Federal Lawsuit Challenging CMS Hemp-CBD Medicare Pilot as Preliminary Injunction Hearing Approaches. WASHINGTON, D.C....
法院在EESystem案中裁定杰森·舒尔卡败诉；下令处以54,034美元的联邦制裁金
Clark County judge finds defendant's public statements were not made in good faith. The ruling caps months of legal proceedings...
法院在 EESystem 案中裁定傑森·舒爾卡敗訴；下令處以 54,034 美元的聯邦制裁金
Clark County judge finds defendant's public statements were not made in good faith. The ruling caps months of legal proceedings...
BioNTech and DualityBio’s Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer
Trastuzumab pamirtecan, an investigational HER2-targeted antibody-drug conjugate, met the primary efficacy endpoint in a Phase 2 cohort of heavily pre-treated...
NeuroSalt Under Investigation: What the 2026 Formulation Transparency Review Reveals About Botanical Ingredients, Dosage Disclosure, and Consumer Verification
A detailed overview of NeuroSalt's five-ingredient plant-based nerve health supplement — covering botanical formula composition, ingredient-level research, dosage disclosure, 60-day...
Gentle Patches Claims Evaluated: 2026 Consumer Interest Rises Around Transdermal Wellness Patch Ingredients, Product Lineup, and Policy Transparency
A timely 2026 release highlighting growing consumer research interest in skin-absorption wellness formats, ingredient themes, product variety, and publicly visible...
Glo & Spa-rkle Aesthetics and Medical Spa Unveils New State-of-the-Art Location in Lubbock, Texas
Join the Grand Opening Celebration on May 1, 2026, for an Evening of Beauty and InnovationLubbock, TX, April 10, 2026...
IVY Rx Claims Evaluated: 2026 Compounded GLP-1 Telehealth Program Details, Monthly Pricing Structure, Clinician Access Model, and Patient Eligibility Information
New 2026 program information covers self-pay pricing tiers, HSA/FSA eligibility, compounded semaglutide and tirzepatide access, three-entity telehealth structure, and key...
ReadyRx NAD+ Rx Claims Evaluated: 2026 Update Highlights Changes in Prescription NAD+ Nasal Spray and Injection Access, Pricing, and Telehealth Eligibility
New 2026 Program Overview Details Compounded NAD+ Therapy Access, Three-Entity Telehealth Structure, and What Patients Should Know Before Starting Clinician-Reviewed...
Replimune Receives Complete Response Letter from the FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma
WOBURN, Mass., April 10, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the...
Pelthos Therapeutics Announces CFO Transition
Senior Vice President, Finance & Accounting John M. Gay named Chief Financial OfficerDURHAM, N.C., April 10, 2026 (GLOBE NEWSWIRE) --...
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BRISBANE, Calif., April 10, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that, on April 8, 2026,...
Mesoblast Receives IND Clearance From FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil® in Duchenne Muscular Dystrophy – CORRECTION
Working with Parent Project Muscular Dystrophy and the Duchenne Registry on patient identification and trial awareness efforts ~15,000 children are...
Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., April 10, 2026 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a biopharmaceutical company developing a new...
Spyre Therapeutics to Host Conference Call to Report SPY001 Part A Induction Topline Results from SKYLINE Trial in Moderate-to-Severe Ulcerative Colitis Patients on April 13, 2026
WALTHAM, Mass., April 10, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company pioneering long-acting antibodies...
Allogene Therapeutics to Announce Interim Futility Analysis Data from its Pivotal Phase 2 ALPHA3 Trial with Cemacabtagene Ansegedleucel (Cema-Cel) in First-Line Consolidation LBCL on Monday, April 13, 2026
SOUTH SAN FRANCISCO, Calif., April 10, 2026 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering...
Checkerspot Introduces Algolein™, a New Line of Specialized Lipids from Microalgae for Personal Care and Cosmetics
Algolein™ debuts with a high-oleic algal oil under the name Algolein™ TG C18/80 designed without genetic modification using microalgae fermentation...
IRADIMED CORPORATION to Participate at the 25th Annual Needham Virtual Healthcare Conference
ORLANDO, Fla., April 10, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) today announced that it will participate in the...
Best Medical Alert Systems 2026: Bay Alarm Medical Awarded Best Medical Alert System
Bay Alarm Medical Recognized for Excellence in Safety and Innovation by Medical DailyConcord, CALIFORNIA, April 10, 2026 (GLOBE NEWSWIRE) --...